Reported Oct 10, 2018 · Terminated
robaxin-750 (methocarbamol tablets, USP), 750 mg, 100-count bottle, Rx Only, Distributed by
Endo Pharmaceuticals, Inc.
High riskUsing this product could cause serious injury, illness or death — stop using it now.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Endo Pharmaceuticals, Inc. · 1400 Atwater Dr · Malvern, PA · 19355-8701
Is this the product you have?
robaxin-750 (methocarbamol tablets, USP), 750 mg, 100-count bottle, Rx Only, Distributed by
3 of 3 products
| # | Product as published |
|---|---|
| 1 | Endo Pharmaceuticals Inc., Malvern, PA 19355 |
| 2 | Manufactured by: Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett Company, Inc., Seymour, IN 47274 |
| 3 | NDC 52244-449-10. |
- Lot codes and dates
Lot #: 216702P1Exp 09/20220409P1Exp 01/21
- Amount recalled
- 2,856 bottles
Where it was sold
- Nationwide
Why it was recalled
Stop using this product now
Labeling: Incorrect Instructions: Dosage information on the immediate container label incorrectly states "Two to four tablets four times daily." rather than the correct dosage of "Two tablets three times daily."
Using this product could cause serious injury, illness or death — stop using it now.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Endo Pharmaceuticals, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.